Sujaatha Narayanan

Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation

Kavita Raj, Sujaatha Narayanan, B. Augustson et al. · Bone Marrow Transplantation · 2004 · 50 citations

Cell Therapy, Transplantation, Allergy +9

Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation

Haowei Sun, Kerry J. Savage, Aly Karsan et al. · Clinical Lymphoma Myeloma & Leukemia · 2015 · 44 citations

Non-hodgkin Lymphomas, Lymphoid Neoplasia, Hematological Malignancy +11

PROTON MR SPECTROSCOPY IN MULTIPLE SCLEROSIS

Douglas L. Arnold, Nicola De Stefano, Sujaatha Narayanan et al. · Neuroimaging Clinics of North America · 2000 · 37 citations · Full text

Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months)

Christopher P. Venner, Joseph M. Connors, Heather J. Sutherland et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2010 · 36 citations

Transplantation Medicine, Immunology, Pathology +18

Response to Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myelogenous Leukemia Relapsing in Chronic and Advanced Phase Following Allogeneic Hematopoietic Stem Cell Transplantation

Matthew P.F. Wright, John D. Shepherd, Michael J. Barnett et al. · Biology of Blood and Marrow Transplantation · 2009 · 33 citations · Full text